HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuxin Zhou Selected Research

LYG 202

1/2018LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer.
9/2015LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuxin Zhou Research Topics

Disease

37Neoplasms (Cancer)
12/2021 - 06/2013
13Breast Neoplasms (Breast Cancer)
01/2022 - 07/2014
6Hypoxia (Hypoxemia)
12/2021 - 09/2013
5Neoplasm Metastasis (Metastasis)
01/2020 - 06/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 06/2013
4Hepatocellular Carcinoma (Hepatoma)
01/2017 - 07/2013
3Inflammation (Inflammations)
01/2020 - 06/2015
3Myocardial Infarction
01/2020 - 01/2015
3Colonic Neoplasms (Colon Cancer)
03/2016 - 05/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 08/2019
2Parkinson Disease (Parkinson's Disease)
01/2022 - 08/2019
2Myeloid Leukemia (Leukemia, Myelocytic)
01/2021 - 11/2014
2Endometriosis
01/2021 - 01/2020
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 09/2014
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 11/2017
2Liver Neoplasms (Liver Cancer)
01/2018 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 01/2015
2Hemorrhage
01/2017 - 01/2015
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 09/2015
2Leukemia
11/2016 - 06/2016
1Stroke (Strokes)
06/2022
1Huntington Disease (Huntington's Disease)
01/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022
1Infections
01/2021
1Prostatic Neoplasms (Prostate Cancer)
09/2020
1Spinal Cord Injuries (Spinal Cord Injury)
01/2020
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020
1Epilepsy (Aura)
01/2020
1Autistic Disorder (Autism)
01/2019
1Disease Progression
01/2018
1Mycoses (Diseases, Fungus)
12/2017
1Triple Negative Breast Neoplasms
11/2017

Drug/Important Bio-Agent (IBA)

18FlavonoidsIBA
12/2021 - 07/2013
10Proteins (Proteins, Gene)FDA Link
04/2021 - 09/2013
105,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
01/2020 - 06/2013
9wogoninIBA
12/2021 - 09/2013
6Glucose (Dextrose)FDA LinkGeneric
01/2018 - 06/2013
5Pharmaceutical PreparationsIBA
01/2021 - 05/2015
4Lactic Acid (Lactate)FDA LinkGeneric
01/2018 - 05/2015
3Long Noncoding RNAIBA
01/2022 - 01/2020
3Messenger RNA (mRNA)IBA
01/2020 - 11/2014
3wogonosideIBA
01/2019 - 06/2016
3Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 07/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 09/2015
2Pyruvic Acid (Pyruvate)IBA
01/2021 - 06/2015
2artemisinin (artemisinine)IBA
11/2019 - 11/2018
2PiperazineIBA
01/2018 - 09/2015
2LYG 202IBA
01/2018 - 09/2015
2TicagrelorIBA
01/2017 - 01/2015
2N(2)-(3-trifluoromethylphenyl)guanineIBA
01/2017 - 01/2015
2omega-Chloroacetophenone (Mace)IBA
01/2017 - 01/2015
2Tirofiban (Aggrastat)FDA Link
01/2017 - 01/2015
2CateninsIBA
11/2016 - 07/2015
2Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
06/2015 - 09/2013
1diazonaphthalenedisulfonic acid (NDS)IBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
12/2021
1Paclitaxel (Taxol)FDA LinkGeneric
12/2021
1NucleotidesIBA
04/2021
1Antisense OligonucleotidesIBA
04/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1A-factor (Streptomyces)IBA
01/2021
1TamoxifenFDA LinkGeneric
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1jasmonic acid (jasmonate)IBA
01/2021
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
01/2021
1Androgen Receptors (Androgen Receptor)IBA
09/2020
1Competitive Endogenous RNAIBA
01/2020
1jisuikangIBA
01/2020
1flavoneIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
08/2019
1PhosphoproteinsIBA
01/2019
1danofloxacinIBA
01/2019
1CytokinesIBA
01/2019
1artenimol (dihydroartemisinin)IBA
11/2018
1ArtesunateIBA
11/2018
1LactonesIBA
11/2018
1ArtemetherFDA Link
11/2018
1SesquiterpenesIBA
11/2018
1Antimalarials (Antimalarial Agents)IBA
11/2018
1oroxylin A-7-O-glucuronideIBA
01/2018
1matrigelIBA
01/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1cadherin 5IBA
01/2018
1Autophagy-Related ProteinsIBA
01/2018
1Conditioned Culture MediaIBA
01/2018
1NF-kappa B (NF-kB)IBA
01/2018
1pyrimidineIBA
11/2017
1phorbolIBA
11/2017
1Phospholipid Transfer ProteinsIBA
11/2017

Therapy/Procedure

7Therapeutics
01/2022 - 01/2017
2Drug Therapy (Chemotherapy)
01/2017 - 07/2013
2Percutaneous Coronary Intervention
01/2017 - 01/2015
1Cognitive Training
06/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2020
1Transcranial Magnetic Stimulation
08/2019